1-8 of 8
Zachary J Walker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Trial: Ex Vivo Drug Sensitivity Testing in Parallel with Physician Selected Selinexor-Based Therapy for Multiple Myeloma

Zachary J. Walker, Deng Wang, Sarah E. Parzych, Lauren T. Reiman, Jacob Joram, Meghan Straubel, Alfonso Roque, Kaylynn Imsande, Katie Zhou, Peter A. Forsberg, Daniel W. Sherbenou
Journal: Blood
Blood (2024) 144 (Supplement 1): 3363.
https://doi.org/10.1182/blood-2024-208407
Published: 2024
Journal Articles

Multiple Myeloma Persister Cells Surviving Bispecific Antibodies and CAR-T Cells Exhibit New CD45+ Expression

Alana L. Keller, Zachary J. Walker, Sarah E. Parzych, Tanisha N. Medha, Lauren T. Reiman, Peter A. Forsberg, Jeremy Rahkola, Meher P. Boorgula, Daniel W. Sherbenou
Journal: Blood
Blood (2024) 144 (Supplement 1): 3273.
https://doi.org/10.1182/blood-2024-210475
Published: 2024
Journal Articles

BCMAxCD3 Bispecific Antibody Elranatamab Is Effective in Patient Myeloma Relapsed after BCMA CAR-T

Alana L. Keller, Sarah E. Parzych, Lauren T. Reiman, Zachary J. Walker, Peter A. Forsberg, Daniel W. Sherbenou
Journal: Blood
Blood (2023) 142 (Supplement 1): 4684.
https://doi.org/10.1182/blood-2023-187385
Published: 2023
Journal Articles

High Ex Vivo Response Rates to CD38/CD28xCD3 Trispecific T Cell Engager in Patients Relapsed after Anti-CD38 and Anti-BCMA Targeted Immunotherapies

Alana Keller, Olivia Perez De Acha, Lauren T Reiman, Zachary J Walker, David S Jayabalan, Ruben Niesvizky, Peter A Forsberg, Peter Kim, Kamlesh Bisht, Hongfang Wang, Helgi van de Velde, Daniel W. Sherbenou
Journal: Blood
Blood (2022) 140 (Supplement 1): 7097–7099.
https://doi.org/10.1182/blood-2022-169072
Published: 2022
Journal Articles

Prolonged Omacetaxine Treatment Alters Fitness and Proteostasis in Multiple Myeloma

Zachary J Walker, Rachel N Steinmetz, Denis J Ohlstrom, Lauren T Reiman, Taylor S Mills, Beau M Idler, Brett M. Stevens, Eric Pietras, Daniel W. Sherbenou
Journal: Blood
Blood (2021) 138 (Supplement 1): 1604.
https://doi.org/10.1182/blood-2021-151953
Published: 2021
Journal Articles

Myeloma Drug Sensitivity Testing to Optimize Retreatment with Anti-CD38 Monoclonal Antibodies in Daratumumab-Refractory Patients

Olivia Perez De Acha, MD, Beau M Idler, Zachary J Walker, BS, MS, Peter A Forsberg, MD, Tomer M Mark, MD MS, Daniel W. Sherbenou, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137819
Published: 2020
Journal Articles

Broad Efficacy of the Translation Inhibitor Omacetaxine in Relapsed/Refractory Multiple Myeloma Samples

Zachary J Walker, BS, MS, Beau M Idler, BA, Michael J VanWyngarden, BS, Brett M. Stevens, PhD, Shelby C Bearrows, BS, Lorraine N Davis, BS, Andrew Hammes, MS, Clayton Smith, MD, Craig T Jordan, PhD, Tomer M Mark, MD MS, Peter A Forsberg, MD, Daniel W Sherbenou, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4404.
https://doi.org/10.1182/blood-2019-121937
Published: 2019
Journal Articles

A Rapid Functional Screen for Small Molecule and Monoclonal Antibody Drug Sensitivity in Multiple Myeloma Patients

Zachary J Walker, MS, Michael J VanWyngarden, BS, Brett M Stevens, PhD, Christophe Langouët-Astrie, MS, Clayton Smith, MD, Brent E Palmer, PhD, Peter A Forsberg, MD, Tomer M Mark, MD MS, Craig T Jordan, PhD, Daniel W Sherbenou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3203.
https://doi.org/10.1182/blood-2018-99-111394
Published: 2018